Dignify Therapeutics (Dignify), a leading developer of therapies for bladder and bowel dysfunction, recently received two ...

The single-center open-label relative bioavailability and dose proportionality study enrolled 30 healthy adult volunteers and compared the pharmacokinetic profile of AD04 when administered as an oral ...

A group at NUS Yong Loo Lin School of Medicine (NUS Medicine) has created a nanoparticle technology that provides an ...

A new therapeutic agent discovered and developed at The Ohio State University will soon be used for cancer treatment at the patient's bedside as part of a clinical trial.

Genmab A/S (Nasdaq: GMAB) announced today new data from the Phase 1/2 study of rinatabart sesutecan (Rina-S), an investigational folate receptor-alpha ...

Small interfering RNA (siRNA) drugs are a class of therapeutic agents that silence specific genes associated with inherited diseases.

Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting fundamental ...

Brain aneurysms claim approximately 500,000 lives worldwide annually. An international team of scientists, including ...

Brette Sember is a retired attorney who has been writing and editing law and legal topics for more than 25 years. She is the author of more than 40 books, is a nationally recognized expert on ...

Volume of distribution at steady state (L/kg) 187 194 194 Table 2. Changes in cough-related symptoms following treatment with levocloperastine 30, 60 and 120 mg/day for 6 days in patients with ...